What is the long-term trend for Gyre Therapeutics, Inc.'s gain loss on sale of property plant equipment?

Over 2 years (2022 to 2024), Gyre Therapeutics, Inc.'s gain loss on sale of property plant equipment has grown at a 306.2% compound annual growth rate (CAGR), from -$4K to -$66K.

Gyre Therapeutics, Inc. GYRE Gain Loss On Sale Of Property Plant Equipment

Gain Loss On Sale Of Property Plant Equipment at other companies

Lumentum Holdings Inc.LITE

$0-100%

CRHCRH

$22M+57.1%

CytokineticsCYTK

$0+100%

Target HospitalityTH

$75K0.0%

Digital RealtyDLR

$42.87M-70.4%

HBT

HBT Financial, Inc.HBT

$0-100%

Segments

By segment

See full

Gyre Pharmaceuticals-$4K+93.9%

Other financials

Income statement

See full

Revenue$22.5M+2.1%

Gross profit$21.3M+0.6%

Operating income-$9.4M-512%

Net income-$8.7M-422%

EPS (diluted)-$0.10—

Balance sheet

See full

Cash & equivalents$37.5M+149%

Total debt$823.0K-48.1%

Total equity$101.3M+48.7%

Total assets$162.0M+24.8%

Cash flow

See full

Operating cash flow$3.2M+2,565%

CapEx$178.0K+45.9%

Free cash flow$3.0M+1,296%

Valuation

See full

Market cap$694.58M-4.7%

Enterprise value$657.9M-8.0%

P/S5.9×-1.3×

Profitability

See full

Gross margin95.1%-1.1pp

Operating margin-0.1%-10.4pp

Net margin6.3%+3.3pp

FCF margin2.6%—

Returns & leverage

See full

Return on equity8.2%+4.2pp

Debt / equity0×0.0×

Current ratio4.6×+1.0×

Where this comes from

Reported directly by Gyre Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:GainLossOnSaleOfPropertyPlantEquipment.

The official record: Gyre Therapeutics, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Gyre Therapeutics, Inc.'s gain loss on sale of property plant equipment.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Gyre Therapeutics, Inc.'s gain loss on sale of property plant equipment?: Gyre Therapeutics, Inc. (GYRE) reported gain loss on sale of property plant equipment of -$16K in Q1 2026.
What is the long-term trend for Gyre Therapeutics, Inc.'s gain loss on sale of property plant equipment?: Over 2 years (2022 to 2024), Gyre Therapeutics, Inc.'s gain loss on sale of property plant equipment has grown at a 306.2% compound annual growth rate (CAGR), from -$4K to -$66K.